Lee Blansett, MBA

MAI Mindset

December 2023 Pathways Impact Study Part 3: Importance of “on-Pathway” Status for Treatment Selection

06/03/2024

Lee Blansett, MBA

This entry of our MAI Mindset column summarizes the third part of a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.

This entry of our MAI Mindset...

06/03/2024

Journal of Clinical Pathways

MAI Mindset

December 2023 Pathways Impact Study Part 2: Impact of Pathway Programs on Treatment Selection

03/27/2024

Lee Blansett, MBA

This entry of our MAI Mindset column summarizes the second part of a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.

This entry of our MAI Mindset...

03/27/2024

Journal of Clinical Pathways

MAI Mindset

December 2023 Pathways Impact Study Part 1: Awareness and Influencers of Use

02/12/2024

Lee Blansett, MBA

In this entry of our MAI Mindset column, Lee Blansett, MBA, summarizes a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.

In this entry of our MAI Mindset...

02/12/2024

Journal of Clinical Pathways

MAI Mindset

Clinical Pathways Impact on Treatment Selection

09/19/2023

Lee Blansett, MBA

In this first entry of our new MAI Mindset column, Lee Blansett, MBA, provides an overview of how in addition to providing benefits, clinical pathways can also present challenges and potential risks for manufacturers.

In this first entry of our new...

09/19/2023

Journal of Clinical Pathways